The IPO Buzz: Boundless Bio Prices IPO at $16.00 Mid-Point – Stock Drops in NASDAQ Debut
Boundless Bio (BOLD) priced its IPO at $16.00 – the mid-point of its range – on just 6.25 million shares – the number of shares in the prospectus – to raise $100.0 million on Wednesday night, March 27, 2024. The Phase 1/Phase 2 cancer biotech’s stock sank in its first day of NASDAQ trading on Thursday, March […]
March 28, 2024 Read More